This study aims to investigate the expression of LSM2 in glioma, its prognostic significance, and the molecular mechanisms through which it influences glioma biology, focusing particularly on its role in alternative splicing and its potential as a therapeutic target. The gene discussed is LSM2; the disease is glioma.